Cite

HARVARD Citation

    Halank, M. et al. (2017). Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study. Respiratory medicine. pp. 50-56. [Online]. 
  
Back to record